@article{19032b71dba145d4a33e61fef50dafa9,
title = "Development of an orally bioavailable selective inhibitor of the menin-MLL",
author = "Zhong, \{Hai Jing\} and Wanhe Wang and Wei Zhou and Liang, \{Jia Xin\} and Cheng, \{Yung Chi\} and Ma, \{Dik Lung\} and Leung, \{Chung Hang\}",
note = "This work is supported by the Science and Technology Development Fund (Macau SAR, China) (No. 0007/2020/A1, 0020/2022/A1), the State Key Laboratory of Quality Research in Chinese Medicine (University of Macau) (SKL-QRCM(UM)-2020-2022), the University of Macau (China) (MYRG2019-00002-ICMS, MYRG2020-00017-ICMS), 2022 Internal Research Grant of SKL-QRCM (University of Macau) (QRCM-IRG2022-011), the National Natural Science Foundation of China, China (No. 22077109, 21775131), the HKBU SKLEBA Research Grant (SKLP\_2223\_P03), the National Natural Science Foundation of China (No. 82204482), the Guangdong Basic and Applied Basic Research Foundation (China) (No. 2021A1515012520), Young Elite Scientists Sponsorship Program by CACM (China) (No. 2021-QNRC2-B22), Guangzhou Basic and Applied Basic Research Foundation (China) (No. 202102020203), and the Fundamental Research Funds for the Central Universities (China) (No. 11620355). A part of the research is supported by a trust fund for Yung-Chi Cheng's lab at Yale University. {\textcopyright} 2022 The Authors.",
year = "2023",
month = sep,
doi = "10.1016/j.gendis.2022.10.005",
language = "English",
volume = "10",
pages = "1735--1738",
journal = "Genes and Diseases",
issn = "2352-4820",
publisher = "Elsevier BV",
number = "5",
}